U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Celldex Therapeutics and Peregrine Pharmaceuticals

Continue Reading

Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on Centene and Molina Healthcare

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on Alexza Pharmaceuticals and Savient Pharmaceuticals

Continue Reading

Advanced Energy Industries and MEMC Electronic Materials on the Upswing After Receiving “Buy” Rating from Citigroup.

RDInvesting Provides Stock Research on Advanced Energy Industries and MEMC Electronic Materials

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on StemCells and ZIOPHARM Oncology

Continue Reading

First Solar and SunPower Surge After Receiving “Buy” Rating From CitiGroup

RDInvesting Provides Stock Research on First Solar and SunPower

Continue Reading

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Research Driven Investing Provides Stocks Research on ArQule and BioCryst Pharmaceuticals

Continue Reading

Solar Industry Impressing Investors With Gains After Dismal 2012

RDInvesting Provides Stock Research on Trina Solar and Yingli Green Energy

Continue Reading

Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on CVS Caremark and Walgreen

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros

Continue Reading